RE:RE:A bad year for MBX...at least so farOk, I still have not sold a single share but.............
Did you expect a stock price of .49.
I still think there a few things combining to make this happen.
1) world events aren't anybody's friend at the moment. Risk stocks get hit the hardest.
2) I still believe this is seen as a Covid stock....they have to prove they are not. Saying it over and over does not appear to be enough....Only a few successful non-covid deals (HPV QAPS's), more VTM customers outside Ontario will send that message.
3) I am still stuck on the words: " It will be a photo finish whether we get a Kinlytic deal by the end of 2021" I think the explanation for the lack of a deal is poor. I do not think anything else Cameron has done at MBX is poor, but they get an "F" from me on this one topic. I watched the MBX for beginners video with Adelaide Capital, and unless I missed it Kinlytic was not even mentioned by name.
4) I would like to know what happened to KRC Insights. Where is the updated analysis. I cant get over the feeling that we dont have it because they didnt like it. Maybe I am wrong.
I think this stock does have the potential to tank. I did not think that earlier. We are dependent on the automation coming on line, and sales delivering the contracts that have been hinted at.
Until then we are in limbo, and the uncertainties are reflected in the stock price. IMO